Zobrazeno 1 - 10
of 73
pro vyhledávání: '"Patrick Jean‐Philippe"'
Autor:
Patricia Mandima, Kristin Baltrusaitis, Grace Montepiedra, Lisa Aaron, Jyoti Mathad, Carolyne Onyango-Makumbi, Mandisa Nyati, James Ngocho, Gift Chareka, Ponego Ponatshego, Gaerolwe Masheto, Katie McCarthy, Patrick Jean-Philippe, Amita Gupta, Lynda Stranix-Chibanda, for the IMPAACT P1078 T. B. APPRISE study team
Publikováno v:
BMC Pregnancy and Childbirth, Vol 23, Iss 1, Pp 1-13 (2023)
Abstract Background This exploratory analysis investigates the prevalence and risk factors of neurocognitive toxicity in postpartum women on HIV treatment in response to a concern of an Isoniazid Preventive Therapy (IPT)/Efavirenz interaction. Trial
Externí odkaz:
https://doaj.org/article/18892fbe445c45b6946a62734fa30727
Autor:
Samantha Calabrese, Matt Perkins, Sonia Lee, Susannah Allison, Gina Brown, Patrick Jean‐Philippe, Nahida Chakhtoura, Jack Moye, Bill G. Kapogiannis
Publikováno v:
Journal of the International AIDS Society, Vol 26, Iss 3, Pp n/a-n/a (2023)
Abstract Introduction Human immunodeficiency virus (HIV) continues to rise in young people among low‐ and middle‐income countries (LMIC). The US National Institutes of Health (NIH) supports the largest public investment in HIV research globally.
Externí odkaz:
https://doaj.org/article/406dad3ded024413afc0a38f288de9e3
Autor:
Lee Fairlie, Miriam Chernoff, Mark F. Cotton, Mutsa Bwakura-Dangarembizi, Avy Violari, Itziar Familiar-Lopez, Linda Barlow-Mosha, Portia Kamthunzi, Katie McCarthy, Patrick Jean-Philippe, Barbara Laughton, Paul E. Palumbo, Michael J. Boivin
Publikováno v:
Frontiers in Pediatrics, Vol 10 (2022)
BackgroundThe International Maternal Pediatric Adolescent AIDS Clinical Trials Network (IMPAACT) P1104s study evaluated neuropsychological outcomes over 96 weeks in children living with HIV (CLHIV) aged 5–11 years at 6 Sub-Saharan African sites to
Externí odkaz:
https://doaj.org/article/a2f18527925c46be9e775519ec675d95
Autor:
Gbolahan Ajibola, Kenneth Maswabi, Michael D. Hughes, Kara Bennett, Molly Pretorius-Holme, Edmund V. Capparelli, Patrick Jean-Philippe, Sikhulile Moyo, Terence Mohammed, Oganne Batlang, Maureen Sakoi, Lucia Ricci, Shahin Lockman, Joseph Makhema, Daniel R. Kuritzkes, Mathias Lichterfeld, Roger L. Shapiro
Publikováno v:
JAIDS Journal of Acquired Immune Deficiency Syndromes. 92:393-398
Autor:
Marlon, Liyanage, Mina, Nikanjam, Lynn, McFadyen, Manoli, Vourvahis, Luise, Rogg, John, Moye, Ellen G, Chadwick, Patrick, Jean-Philippe, Mark, Mirochnick, Kyle, Whitson, Sarah, Bradford, Edmund V, Capparelli, Brookie M, Best
Publikováno v:
Pediatric Infectious Disease Journal. 41:885-890
Treatment and prophylaxis options for neonatal HIV are limited. This study aimed to develop a population pharmacokinetic model to characterize the disposition of maraviroc in neonates to inform dosing regimens and expand available options.Using marav
Autor:
Lameck Chinula, Lauren Ziemba, Sean Brummel, Katie McCarthy, Anne Coletti, Chelsea Krotje, Benjamin Johnston, Kevin Knowles, Sikhulile Moyo, Lynda Stranix-Chibanda, Risa Hoffman, Paul E Sax, Jeffrey Stringer, Nahida Chakhtoura, Patrick Jean-Philippe, Violet Korutaro, Haseena Cassim, Lee Fairlie, Gaerolwe Masheto, Ceejay Boyce, Lisa M Frenkel, K Rivet Amico, Lynette Purdue, Roger Shapiro, Blandina Theophil Mmbaga, Faeezah Patel, Jean van Wyk, James F Rooney, Judith S Currier, Shahin Lockman, Brookie M. Best, Cheryl D Blanchette, Renee Browning, Nagawa Jaliaah, Mark Mirochnick, William A. Murtaugh, Emmanuel Patras, Frances Whalen, Jeremiah D. Momper, Ponego L. Ponatshego, Lesedi Tirelo, Boitshepo J. Seme, Georginah O. Modise, Mpho S. Raesi, Marian E. Budu, Moakanyi Ramogodiri, Ricardo H. Oliveira, Cristina B Hofe, Thalita Fernandes de Abreu, Lorena M. Pestanha, Esaú João, Leon C. Sidi, Trevon Fuller, Maria L.S Cruz, Jorge Pinto, Flãvia Ferreira, Mãrio Correa Jr, Juliana Romeiro, Jose H. Pilotto, Luis E.B.C Fernandes, Luiz F. Moreira, Ivete M. Gomes, Shilpa Naik, Neetal Nevrekar, Vidya Mave, Aarti Kinikar, Elizea Horne, Hamisha Soma-Kasiram, Avy Violari, Sisinyana R. Mathiba, Mandisa Nyati, Gerhard Theron, Jeanne de Jager, Magdel Rossouw, Lindie Rossouw, Sherika Hanley, Alicia C. Desmond, Rosemary Gazu, Vani Govender, Amphan Chalermchockcharoenkit, Manopchai Thamkhantho, Peerawong Werarak, Supattra Rungmaitree, Jullapong Achalapong, Lukkana Sitiritkawin, Tim R. Cressey, Pra-ornsuda Sukrakanchana, Linda Aurpibul, Fuanglada Tongprasert, Chintana Khamrong, Sopida Kiattivej, Deo Wabwire, Enid Kabugo, Joel Maena, Frances Nakayiwa, Victoria Ndyanabangi, Beatrice Nagaddya, Rogers Sekabira, Justus Ashaba, Charles D. Mitchell, Adriana Drada, Grace A. Alvarez, Gwendolyn B. Scott, Mobeen Rathore, Saniyyah Mahmoudi, Adnan Shabbir, Nizar Maraqa, Patricia F. Mandima, Mercy Mutambanengwe, Suzen Maonera, Gift Chareka, Teacler Nematadzira, Vongai Chanaiwa, Taguma A. Matubu, Kevin Tamirepi, Sukunena Maturure, Tsungai Mhembere, Tichaona Vhembo, Tinashe Chidemo
Publikováno v:
The Lancet HIV.
Autor:
Mina Nikanjam, Lana Tran, Ellen G. Chadwick, Mutsa Bwakura-Dangarembizi, Carolyn Bolton Moore, Pearl Samson, Stephen A. Spector, Nahida Chakhtoura, Patrick Jean-Philippe, Lisa Frenkel, Bonnie Zimmer, Alex Benns, Jennifer Libous, Edmund V. Capparelli
Publikováno v:
AIDS
Dosing efavirenz (EFV) in children less than 3 years of age is challenging due to large variability in drug levels. This study evaluated differences in pharmacokinetics with tuberculosis (TB) therapy, formulation, age, and CYP2B6 genotype.Pharmacokin
Autor:
Michael Hughes, Joseph Makhema, Oganne Batlang, Maureen Sakoi, Kara Bennett, Pilar Garcia-Broncano, Shahin Lockman, Daniel R. Kuritzkes, Kenneth Maswabi, Roger L. Shapiro, Patrick Jean-Philippe, Mathias Lichterfeld, Sikhulile Moyo, Terrence Mohammed, Gbolahan Ajibola
Publikováno v:
Clin Infect Dis
Background The impact of very early infant treatment on human immunodeficiency virus (HIV) reservoir, and markers for treatment success, require study. Methods The Early Infant Treatment Study (EIT) enrolled 40 children living with HIV started on ant
Publikováno v:
Journal of Women's Health
About 12.5% of all maternal deaths in the United States are due to infectious causes. This proportion, although stable during the past three decades, represents an increase in infectious causes of mortality, as the overall mortality rate in U.S. preg
Autor:
Adriana Weinberg, Gerhard Theron, Sarah Bradford, Timothy R. Sterling, Patrick Jean-Philippe, Grace Montepiedra, Nahida Chakhtoura, Amita Gupta, Sylvia M LaCourse, Soyeon Kim, Scott R. Evans
Publikováno v:
Clin Infect Dis
Background Tuberculosis (TB-)-preventive therapy (TPT) among pregnant women reduces risk of TB in mothers and infants, but timing of initiation should consider potential adverse effects. We propose an analytical approach to evaluate the risk–benefi